Abbott Laboratories (Pakistan) Limited (ABOT)
Explore Abbott Laboratories (Pakistan) Limited (ABOT) public company financials, recorded price history, dividend information and corporate announcements. Educational research, no buy/sell calls.
Company business
Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.
Dated public observations
- Recorded closing price
- PKR 930.25 · 2026-10-13
- Annual EPS
- PKR 81.37 · period 2025
- Published company P/E
- 10.64 · company snapshot 2026-10-13
- Recorded price-history sessions
- 273
- Fiscal-year dividend per share
- 40
Book closures and corporate events
Snapshot 2026-10-13. Missing rows do not prove there are no events.
Official company disclosure headings
- 2026-08-28 · Transmission of Quarterly Financial Statements for the Period Ended June 30, 2026
- 2026-08-28 · Financial Results for the Half Year Ended June 30 2026
- 2026-08-20 · Board Meeting
- 2026-06-10 · Re-Appointment of Chairman
- 2026-06-10 · Re-Appointment of Chief Executive Officer
- 2026-06-02 · Dissemination of Video Recording Link of Corporate Briefing Session (CBS) 2026
- 2026-05-25 · Revised Presentation of Corporate Briefing Session 2026
- 2026-05-22 · Presentation of Corporate Briefing Session 2026
- 2026-04-30 · Certified copy of Resolution passed at the 77th Annual General Meeting
- 2026-04-29 · Transmission of Quarterly Report for the Period Ended March 31, 2026
Headings are not full documents; financial impact is not inferred from an unread notice.
How to use this research
Compare the business, financial period, liquidity, historical price variation and valuation assumptions. The interactive research screen has twelve engines with sources and missing-data notes. This tool does not issue buy/sell/hold calls.
Verify the official PSX company source · Review our methods · Learn to read financials